The following table shows the list of Horizon 2020 projects developed by "STICHTING LYGATURE". Projects are ordered by starting date.
Click on table headers to rearrange data.
# | acronym | programme | role | EC contrib. | start | views |
---|---|---|---|---|---|---|
1 | RADAR-CNS | H2020-EU.3.1.7. | participant | 1˙345˙962.00 | 2016-04-01 | 856 |
2 | ADAPT-SMART | H2020-EU.3.1.7.13. | coordinator | 522˙000.00 | 2015-07-01 | 707 |
3 | RESTORE | H2020-EU.3.1.3. | participant | 185˙000.00 | 2018-01-01 | 743 |
4 | RADAR-AD | H2020-EU.3.1.7. | participant | 551˙306.00 | 2019-01-01 | 289 |
5 | FAIRplus | H2020-EU.3.1.7. | participant | 296˙511.00 | 2019-01-01 | 301 |
6 | ESCulab | H2020-EU.3.1.7. | coordinator | 1˙434˙943.00 | 2018-12-01 | 356 |
7 | PD-MIND | H2020-EU.3.1.7. | participant | 100˙937.00 | 2019-05-01 | 284 |
8 | GNA NOW | H2020-EU.3.1.7. | coordinator | 620˙681.00 | 2019-07-01 | 277 |
9 | Trials@Home | H2020-EU.3.1.7. | participant | 181˙227.00 | 2019-09-01 | 322 |
10 | Immune-Image | H2020-EU.3.1.7. | participant | 450˙000.00 | 2019-10-01 | 396 |
totale | 5˙688˙567.00 |
This organization collaborated with partners in 17 countries.
Within the project RADAR-CNS this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | NL | STICHTING VUMC | STICHTING VUMC (REC) |
participant | CZ | MSD | MSD CZECH REPUBLIC SRO (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | UK | BIOGEN | BIOGEN IDEC LIMITED (PRC) |
participant | UK | Intel | INTEL CORPORATION (UK) LIMITED (PRC) |
participant | DE | SAG | SOFTWARE AG (PRC) |
participant | ES | CIBER | CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P. (REC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | ES | VHIR | FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA (REC) |
participant | NL | IMEC-NL | STICHTING IMEC NEDERLAND (REC) |
participant | IT | UniBg | UNIVERSITA' DEGLI STUDI DI BERGAMO (HES) |
participant | DE | UNIA | UNIVERSITAET AUGSBURG (HES) |
participant | IT | IRCCS- FBF | PROVINCIA LOMBARDO VENETA - ORDINEOSPEDALIERO DI SAN GIOVANNI DI DIO- FATEBENEFRATELLI (REC) |
participant | US | NWU | NORTHWESTERN UNIVERSITY (HES) |
participant | DK | CRD | REGION HOVEDSTADEN (PUB) |
participant | DE | GABO:mi | GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG (PRC) |
participant | IT | USR | UNIVERSITA VITA-SALUTE SAN RAFFAELE (HES) |
participant | DE | UNI PASSAU | UNIVERSITAT PASSAU (HES) |
participant | DE | UKLFR | UNIVERSITAETSKLINIKUM FREIBURG (HES) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
participant | UK | UoN | THE UNIVERSITY OF NOTTINGHAM (HES) |
coordinator | UK | KCL | KING'S COLLEGE LONDON (HES) |
participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | DE | CHA | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
Within the project ADAPT-SMART this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | CH | SHIRE | SHIRE INTERNATIONAL GMBH (PRC) |
participant | UK | AbbVie | AbbVie Ltd (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | IT | AIFA | AGENZIA ITALIANA DEL FARMACO (PRC) |
participant | FR | Lysogene | LYSOGENE (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | UK | Astellas | ASTELLAS PHARMA EUROPE LTD (PRC) |
participant | NL | ZIN | ZORGINSTITUUT NEDERLAND (PUB) |
participant | FR | IPSEN | IPSEN INNOVATION SAS (PRC) |
participant | FR | HAS | HAUTE AUTORITE DE SANTE (PUB) |
participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
participant | BE | Amgen | AMGEN (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | UK | EMA | THE EUROPEAN MEDICINES AGENCY (PUB) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | DE | Bayer | Bayer Pharma AG (PRC) |
participant | US | MIT | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (HES) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | DK | DHMA | SUNDHEDSSTYRELSEN (PUB) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project RESTORE this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | BE | ICO | ICOMETRIX NV (PRC) |
participant | BE | UZA | UNIVERSITAIR ZIEKENHUIS ANTWERPEN (REC) |
participant | NL | SQ | Stichting Sanquin Bloedvoorziening (REC) |
participant | ES | ICS - HUB | INSTITUT CATALA DE LA SALUT (PUB) |
participant | ES | UNAV | UNIVERSIDAD DE NAVARRA (HES) |
participant | DE | WWU | WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER (HES) |
coordinator | BE | UANTWERPEN | UNIVERSITEIT ANTWERPEN (HES) |
Within the project RADAR-AD this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | CH | Altoida AG | ALTOIDA AG (PRC) |
participant | NL | STICHTING VUMC | STICHTING VUMC (REC) |
participant | NL | CBG/MEB | AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN (PUB) |
participant | NL | THE HYVE | THE HYVE BV (PRC) |
participant | UK | TAKEDA | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | DE | SAG | SOFTWARE AG (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | LU | AE | ALZHEIMER EUROPE (OTH) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | EL | CERTH | ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS (REC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
coordinator | UK | KCL | KING'S COLLEGE LONDON (HES) |
participant | DE | Fraunhofer | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (REC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project FAIRplus this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | BAY | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | UK | PHACTS | OPEN PHACTS FOUNDATION LBG (REC) |
participant | NL | The Hyve | THE HYVE BV (PRC) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | ES | IMIM | FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM (REC) |
participant | CH | SIB | SIB INSTITUT SUISSE DE BIOINFORMATIQUE (REC) |
participant | ES | BSC | BARCELONA SUPERCOMPUTING CENTER - CENTRO NACIONAL DE SUPERCOMPUTACION (REC) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | FR | UPS-IRIT | UNIVERSITE PAUL SABATIER TOULOUSE III (HES) |
participant | UK | HWU | HERIOT-WATT UNIVERSITY (HES) |
participant | LU | UNILU | UNIVERSITE DU LUXEMBOURG (HES) |
participant | UK | UNIMAN | THE UNIVERSITY OF MANCHESTER (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | SE | AZ | ASTRAZENECA AB (PRC) |
participant | NL | UM | UNIVERSITEIT MAASTRICHT (HES) |
participant | DE | FHG | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (REC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
coordinator | DE | EMBL | EUROPEAN MOLECULAR BIOLOGY LABORATORY (REC) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
Within the project ESCulab this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | NL | MTR | MERCATORIAL BV (PRC) |
participant | NL | MLD | MERCALEADS BV (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | UK | BSC | BIOASCENT DISCOVERY LIMITED (PRC) |
participant | NL | PPSC | PIVOT PARK SCREENING CENTRE BV (REC) |
participant | DE | TRS | TAROS CHEMICALS GMBH & CO KG (PRC) |
participant | DE | GRT | GRUNENTHAL GMBH (PRC) |
participant | FR | EDL | EDELRIS SAS (PRC) |
participant | UK | SYG | SYGNATURE DISCOVERY LIMITED (PRC) |
participant | CH | MMV | Medicines for Malaria Venture (REC) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | NL | SCM | SYNCOM BV (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | FR | IdRS | INSTITUT DE RECHERCHES SERVIER (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | UNIVDUN | UNIVERSITY OF DUNDEE (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project PD-MIND this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | NO | NORGES PF | NORGES PARKINSONFORBUND (OTH) |
participant | UK | PARKINSON'S UK | PARKINSON'S DISEASE SOCIETY OF THEUNITED KINGDOM LBG (OTH) |
participant | NO | SUH | HELSE STAVANGER HF (OTH) |
participant | UK | UNEXE | THE UNIVERSITY OF EXETER (HES) |
participant | IT | UDA | UNIVERSITA DEGLI STUDI GABRIELE D'ANNUNZIO DI CHIETI-PESCARA (HES) |
participant | CZ | MU | Masarykova univerzita (HES) |
participant | DE | TUD | TECHNISCHE UNIVERSITAET DRESDEN (HES) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
coordinator | UK | KCL | KING'S COLLEGE LONDON (HES) |
Within the project GNA NOW this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | NOS | NOSOPHARM (PRC) |
participant | FR | Bioaster | BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE (REC) |
participant | UK | NBT | NORTH BRISTOL NATIONAL HEALTH SERVICE TRUST (REC) |
participant | DE | EVT | EVOTEC INTERNATIONAL GMBH (PRC) |
participant | DE | HZI | HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH (REC) |
participant | UK | UOL | THE UNIVERSITY OF LIVERPOOL (HES) |
participant | DE | Fraunhofer | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (REC) |
participant | NL | ERASMUS | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
participant | AT | MUW | MEDIZINISCHE UNIVERSITAET WIEN (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project Trials@Home this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | IQVIA | IQVIA RDS FRANCE (PRC) |
participant | BE | Covance | COVANCE CLINICAL AND PERIAPPROVAL SERVICES (PRC) |
participant | UK | MRN | MEDICAL RESEARCH NETWORK LIMITED (PRC) |
participant | UK | eClinicalHealth | ECLINICALHEALTH LTD (PRC) |
participant | NL | MLCF | STICHTING MLC FOUNDATION (OTH) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | IL | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED (PRC) |
participant | FR | DREEM | DREEM (PRC) |
participant | NL | UPPMD | STICHTING UNITED PARENT PROJECTS MUSCULAR DYSTROPHY (OTH) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | UK | Allergan | ALLERGAN LIMITED (PRC) |
participant | BE | VT | VITAL TRANSFORMATION (PRC) |
participant | CH | Medtronic | MEDTRONIC INTERNATIONAL TRADING SARL (PRC) |
participant | ES | FISABIO | FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA (REC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | NL | JCR | JULIUS CLINICAL RESEARCH BV (PRC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI Pharma | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | EL | CERTH | ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS (REC) |
participant | AT | JOANNEUM | FH JOANNEUM GESELLSCHAFT MBH (HES) |
participant | CH | Novartis | NOVARTIS PHARMA AG (PRC) |
participant | DK | SDU | SYDDANSK UNIVERSITET (HES) |
coordinator | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | SE | AZ | ASTRAZENECA AB (PRC) |
participant | BE | IDF Europe | FEDERATION INTERNATIONALE DU DIABETE REGION EUROPE AISBL (OTH) |
participant | UK | UNIVDUN | UNIVERSITY OF DUNDEE (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | NL | UU | UNIVERSITEIT UTRECHT (HES) |
Within the project Immune-Image this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | NL | Lawrencium | LAWRENCIUM LEGAL BV (PRC) |
participant | US | ImaginAb | IMAGINAB, INC (PRC) |
participant | SE | Antaros | ANTAROS MEDICAL AB (PRC) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
coordinator | NL | VUmc | STICHTING VUMC (REC) |
participant | NL | TTOP | TTOPSTART BV (PRC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
participant | ES | VHIO | FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON (REC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | ES | VHIR | FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | BE | VIB | VIB (REC) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | DE | WWU | WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER (HES) |
participant | BE | VUB | VRIJE UNIVERSITEIT BRUSSEL (HES) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
participant | DE | EKUT | EBERHARD KARLS UNIVERSITAET TUEBINGEN (HES) |
participant | FR | CEA | COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (REC) |